Generative AI and health misinformation: production, propagation, and mitigation-a systematic review
Abstract
Background: Generative artificial intelligence technologies have disrupted information ecosystems, posing new threats to public health by enabling rapid, scalable manufacture of convincing but false health stories. This systematic review synthesizes evidence on how generative AI reconfigures health misinformation creation, dissemination, and moderation.
Methods: In line with PRISMA 2020, 15 empirical studies published between January 2023 and August 2025 were included. Databases consulted were MEDLINE (via PubMed), Embase, Scopus, Web of Science Core Collection, ACM Digital Library, IEEE Xplore, PsycINFO, Communication & Mass Media Complete, arXiv, and medRxiv/SSRN. Studies were contrasted on the basis of production capacity, propagation dynamics, and efficacy of mitigation at technical, sociotechnical, and governance layers.
Results: The synthesis indicates that generative AI substantially increases the volume, speed, and perceived credibility of health disinformation production, while altering its propagation dynamics. Users often struggle to distinguish AI‑generated from human‑authored health misinformation, and their sharing intentions are not tightly coupled with perceived accuracy. Existing detection systems show limited performance against AI‑generated content, and while labeling interventions can reduce perceived accuracy, their effects are context‑dependent.
Conclusion: Generative AI transforms the health misinformation landscape by lowering barriers to creation and…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Learning from First-Generation Qualitative Approaches in the IS Discipline: An Evolutionary View and Some Implications for Authors and Evaluators (PART 1/2)
- Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models
- Prosthesis: New Technological Opportunities and Innovative Biomedical Devices
- The history and future of neural modeling for cochlear implants
- Ryanodine receptors: waking up from refractoriness
- Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.